645 filings
Page 2 of 33
8-K
vk1bgpaqklbzk49b
22 Dec 23
Departure of Directors or Certain Officers
8:00am
8-K
025omet
15 Nov 23
Departure of Directors or Certain Officers
7:30am
8-K
af1qn233b12vsmd
14 Nov 23
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
12:00am
8-K
z84pzt7
28 Sep 23
Departure of Directors or Certain Officers
4:01pm
8-K
tpv8hm9 s8
14 Aug 23
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim
4:16pm
8-K
xmjw pemj4dazzgvym
5 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
115iat01egoc mjou
12 Jun 23
Material Modifications to Rights of Security Holders
4:15pm
8-K
l6uewjizchxev29r1rkp
10 May 23
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
7:09am
DEFA14A
ypct8
25 Apr 23
Additional proxy soliciting materials
5:06pm
8-K
pxy80
4 Apr 23
Entry into a Material Definitive Agreement
5:11pm
8-K
jk1aa b9e6m
3 Apr 23
Entry into a Material Definitive Agreement
8:00am
8-K
zp9 8cz800705i
30 Mar 23
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
7:41am
8-K
3zpfcmtejw7 a0mbgvc
7 Mar 23
Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
7:07am
8-K
15gx5
9 Jan 23
Regulation FD Disclosure
8:38am